JSE ticker · APN
Aspen Pharmacare Hldgs Ltd (APN) Share Price & Latest SENS Announcements
Aspen Pharmacare Holdings Limited
Track Aspen Pharmacare Holdings Limited (APN) share price moves, recent SENS announcements, company profile details, and Healthcare sector, drug manufacturers - specialty & generic, all in one place.
Latest SENS Announcements — Aspen Pharmacare Hldgs Ltd (APN)
10 most recent- 20 Jul Regulatory Approval
ASPEN PHARMACARE HOLDINGS LIMITED - Health Canada approves Aspen-Semaglutide
- 09 Jul Board/Governance
ASPEN PHARMACARE HOLDINGS LIMITED - Proposed Succession and Board Composition Update
- 02 Jul Shareholder Notice
ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122 (3)(b) of the Companies Act and Section 6.54 of the JSE Listings Requirements
- 25 Jun Director Dealings
ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Prescribed Officer
- 22 Jun Board/Committee Change
ASPEN PHARMACARE HOLDINGS LIMITED - Change in Chairmanship of the Audit and Risk Committee
- 29 May Disposal
ASPEN PHARMACARE HOLDINGS LIMITED - Completion of the divestment of Aspen APAC
- 21 May Director Dealings
ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director and Prescribed Officer
- 05 May Director Dealings
ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director and Prescribed Officer
- 05 May Operational Update
ASPEN PHARMACARE HOLDINGS LIMITED - Commercial Release of Locally Manufactured Human Insulin
- 30 Apr Board Change
ASPEN PHARMACARE HOLDINGS LIMITED - Resignation of Executive Director
SENS-AI Intelligence is locked
Sign in free to unlock the signal cockpit, current read, deltas, full metrics board and the combined narrative for every JSE stock.
Free account · no card required
Price · Close
- Trend
- —
- Momentum
- —
- RSI 14
- —
- 30D Vol
- —
What Changed
Delta viewLatest SENS 6h ago: "ASPEN PHARMACARE HOLDINGS LIMITED - Health Canada approves Aspen-Semaglutide" — reading mixed.
Market
Valuation
Technicals
Why It Matters
Combined viewNot enough cross-signal evidence yet to compose a combined read.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
- Exchange
- Johannesburg
- Currency
- ZAc
- Employees
- 9,128
- Country
- South Africa
- Website
- https://www.aspenpharma.com
Get daily SENS-AI analysis on every JSE SENS announcement.
Sentiment scoring · Key points · Verdict on every filing.
→ Sign Up Free